T U BE R C U L O S I S
S A N U J A K
I V T H B S C B
S J B C O N
2.
INTRODUCTION
01
DEFINITION
02
MAGNITUDE OF THEPROBLEM
03
EPIDEMIOLOGICAL TRAID
04
TA B L E O F C O N T E N T S
MODE OF TRANSMISSION
05
INCUBATION PERIOD
06
CLINICAL FEATURES
07
PREVENTION AND CONTROL
08
3.
Tuberculosis is acommunicable disease suffered by all ages.
Hippocrates called this disease " PHITHESIS" which means
'to dry of disease accelerated greatly'. It spread y inhaling tiny
droplets of saliva from the cough or sneeze of an infected
person.
It is a slowly spreading chronic granulomatous bacterial
infection, characterized by gradual weight loss. Tuberculosis
is the world's second most common cause of death from
infectious diseases after HIV/AIDS and COVID-19.
I N T R O D U C T I O N
4.
D E FI N I T I O N
Tuberculosis is an infectious disease of the
parenchyma of the lung caused y mycobacterium
tuberculosis characterized y the formation of tubercle.
5.
M A GN I T U D E O F T H E P R O B L E M
• A total of 1.6 million people died from TB in 2021.
• In 2021, an estimated 10.6 million people fell ill
with tuberculosis worldwide.
• In 2021,1.2 million children fell ill with
tuberculosis globally
6.
E P ID E M I O L O G I C A L T R I A D
• The causative organism of tuberculosis is Mycobacterium tuberculosis.
• There are 2 strains: The human strain is responsible for the vast majority
of cases occurring among human beings and the bovine strain is
responsible for infecting cattle and other animals.
• The source of infection is human cases hose sputum is positive for
tubercle bacilli and milk from infected animals.
• Patients are infected as long as they remain untreated.
CAUSATIVE AGENT
7.
C O NT . .
• Tuberculosis affects all ages and is more
prevalent in males than females.
HOST FACTORS
8.
C O NT
• Poor quality of life.
• Poor housing conditions.
• Overcrowding.
• Population explosion.
• Malnutrition
• Lack of education and awareness
• Large families.
• Early marriages
ENVIRONMENTAL FACTORS
9.
• Transmitted mainlyby droplet nuclei generated by
sputum-positive patients.
• Ingestion of contaminated food and milk
M O D E O F T R A N S M I S S I O N
10.
• R an g e s b e t w e e n 3 - 6 w e e k s .
INCUBATION PERIOD
CONT..
C h es t p a i n
H e m o p h y s i s
N i g h t s w e a t s
13.
CONT..
M u sc l e a t r o p h y
A n o r e x i a
F a t i g u e
14.
LAB
INVESTIGATION
• M an t o u x t e s t
• S p u t u m e x a m i n a t i o n
• S p u t u m c u l t u r e
• M a s s m i n i a t u r e r a d i o g r a p h y
• C h e s t X - r a y
CASE
FINDING
• E ar l y d e t e c t i o n o f a l l
c a s e s .
• F i n d i n g t h e s u s p e c t s .
17.
• The screeningtest is conducted by injecting a
tuberculin-purified protein derivative of 0.1 ml
into the inner surface of the forearm.
• A tuberculin syringe is used to administer this
intradermal injection.
• The injection will produce a pale elevation of
the skin
• The reaction of the skin test should be read
within 48-72 hours of administration.
MANTOUX TEST
18.
It is advisedfor the person whose sputum
smear is negative but has chest symptoms.
• Sputum smears collected from suspected
persons' should e collected early in the
morning on 3 successive days.
• The presence of at least 10,000 organisms
per ml of sputum is considered TB positive.
SPUTUM CULTURE
SPUTUM EXAMINATION
CHEMOTHE
RAPY
• F ir s t l i n e d r u g s
• S e c o n d l i n e d r u g s
A N T I - T U B E R C U L O S I S D R U G S
A R E G R O U P E D I N T O 2
21.
FIRST LINE DRUGS
Bactericidaldrugs
• Rifampcin:10-12mg/kg body
• weight, orally
• Isoniazid:4-5mg/kg body weight
• Streptomycin:0.75-1g, injection
• Pyrazinamide:30mg/kg body
weight, tid/bid per day or 45-
30mg/kg body weight twice weekly
S E CO N D L I N E D R U G S
• Ethionamide
• Prothionamide
• Ofloxacin
• Viomycin
24.
SHORT COURSE CHEMOTHERAPY
Rifampicinand Pyrazinamide to the anti-TB regimen and
reduced the duration of treatment from 18 months to 6-8
months.
2 phases
• Intensive phase
• Continuation phase
25.
D O T( D I R E C T LY O B S E RV E D T H E R A P Y
Directly observed therapy is a short course and a program
to help cure TB.
DOT by definition means watching clients swallow each
dose of anti-TB medications.
26.
BCG stands forBacilli of Calmette and Guerin.There are two
types of BCG vaccines.
• Liquid dried
• Freeze-dried.
BCG VACCINATION